跳至主要内容
临床试验/KCT0007528
KCT0007528尚未招募未知

A human study to evaluate the efficacy and safety of herbal complex extract NS2107 on climacteric symptoms in menopausal women

Seoul National University Hospital0 个研究点目标入组 80 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
80

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
45(Year) 至 65(Year)(—)
性别
Female

入选标准

  • 1) Subject who agrees to participate in the study and signs the informed consent form
  • 2) Women aged 45–65 years
  • 3) Post-menopausal (amenorrhea = 12 months) or peri-menopausal (amenorrhea = 3 month & follicle stimulating hormone (FSH) > 30 IU/L)
  • 4) Moderate or severe menopausal symptoms (Kupperman index score = 15)
  • 5) Subject with an average daily hot flash score of 10 or higher for the past 1 week

排除标准

  • 1) Subjects who have surgical or chemotherapy induced menopause, vaginal bleeding without diagnosis
  • 2) Subjects with a history of endometrial hyperplasia, cervical cancer, endometrial cancer, breast cancer or breast disease, sex hormone-related cancer, etc., or abnormal findings in breast examination results or vaginal ultrasonography
  • 3) Subjects with unknown uterine bleeding after 1 year of menopause
  • 4) Abnormality in renal or liver function, uncontrolled hypertension
  • 5) Uncontrolled thyroid disease, diabetes mellitus, hyperlipidemia
  • 6) Subjects who have severe mental disorders such as depression or anxiety disorder, or are currently taking psychiatric drugs such as antidepressants
  • 7) History of Severe migraine within 1 year, thromboembolism, cerebrovascular disease, myocardial infarction, unstable angina, coronary artery plastic surgery
  • 8) Within 3 months of the first visit, hormone preparations such as female hormones, similar hormone preparations, selective estrogen receptor modulators, drugs that may affect menopausal symptoms was used
  • 9) History of drug abuse, or alcoholism
  • 10) Subjects who consumed the functional food or oriental medicine that can affect menopausal health, blood glucose, blood lipids, blood circulation within 1 months prior to the first visit
  • 11) Subjects who performed continuous high-intensity exercises at least 1 months prior to the first visit
  • 12) Allergy (hypersensitivity) to any of the materials used in the study
  • 13) Subject who participated in other clinical trial within 1 month
  • 14) Subjects who are pregnant or planning to become pregnant
  • 15) Other cases considered inappropriate for the clinical trial by the investigator

研究者

相似试验